Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
CALL
Iridium Communications
IRDM
$5.29B
| $1.8M | ﹤0.01% |
35,000
| – | – |
|
3952
CALL
Wynn Resorts
WYNN
$10.6B
| $1.8M | ﹤0.01% |
21,800
| – | – |
|
3953
PDF Solutions
PDFS
$2.07B
| $1.79M | ﹤0.01% |
62,645
+22,831
| +57% | +$617K |
|
3954
AllianceBernstein
AB
$3.47B
| $1.79M | ﹤0.01% |
51,951
+22,242
| +75% | +$824K |
|
3955
Simulations Plus
SLP
$371M
| $1.79M | ﹤0.01% |
48,824
+3,687
| +8% | +$155K |
|
3956
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$159M
| $1.78M | ﹤0.01% |
+23,377
| New | +$1.78M |
|
3957
Schwab International Equity ETF
SCHF
$68.7B
| $1.78M | ﹤0.01% |
110,704
+79,492
| +255% | +$1.24M |
|
3958
Warby Parker
WRBY
$3.25B
| $1.78M | ﹤0.01% |
132,133
-87,429
| -40% | -$1.34M |
|
3959
CEVA Inc
CEVA
$1.08B
| $1.78M | ﹤0.01% |
69,667
-90,378
| -56% | -$2.43M |
|
3960
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
| $1.78M | ﹤0.01% |
40,624
-26,445
| -39% | -$1.14M |
|
|
SLGC
3961
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.78M | ﹤0.01% |
709,294
-194,755
| -22% | -$543K |
|
|
BRY
3962
DELISTED
Berry Corp
BRY
| $1.77M | ﹤0.01% |
221,676
+4,230
| +2% | +$36.2K |
|
3963
ProFrac Holding
ACDC
$782M
| $1.77M | ﹤0.01% |
70,369
+57,445
| +444% | +$1.27M |
|
3964
Cullinan Oncology
CGEM
$1.14B
| $1.77M | ﹤0.01% |
167,890
-158,860
| -49% | -$1.93M |
|
|
OMIC
3965
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.77M | ﹤0.01% |
29,352
-2,029
| -6% | -$136K |
|
|
PNT
3966
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.76M | ﹤0.01% |
241,651
+62,965
| +35% | +$467K |
|
3967
CALL
Endava
DAVA
$156M
| $1.76M | ﹤0.01% |
+23,000
| New | +$1.71M |
|
3968
SmartFinancial
SMBK
$888M
| $1.76M | ﹤0.01% |
63,903
+7,147
| +13% | +$201K |
|
3969
Peoples Bancorp
PEBO
$1.47B
| $1.75M | ﹤0.01% |
62,095
+33,181
| +115% | +$976K |
|
|
B
3970
PUT
Barrick Mining
B
$73.2B
| $1.75M | ﹤0.01% |
+102,000
| New | +$1.62M |
|
3971
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.24B
| $1.75M | ﹤0.01% |
23,000
+1,000
| +5% | +$87.4K |
|
3972
Freedom Holding
FRHC
$9.49B
| $1.74M | ﹤0.01% |
29,966
+15,275
| +104% | +$877K |
|
3973
Viper Energy
VNOM
$14.7B
| $1.74M | ﹤0.01% |
54,675
-169,292
| -76% | -$5.46M |
|
3974
NETGEAR
NTGR
$635M
| $1.74M | ﹤0.01% |
95,905
+9,229
| +11% | +$182K |
|
3975
Veru
VERU
$37.4M
| $1.74M | ﹤0.01% |
32,882
+10,198
| +45% | +$840K |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.